Not exact matches
Cancer
vaccines are largely not regarded
as a standalone treatment within the scientific community, and immunotherapy stills demand several
years of intense research.
My 13
year old son has autism
as a result of a
vaccine injury.
Outlook: Seqirus, CSL's flu
vaccines arm, boosted sales 43 per cent
as customers flocked to its new quadrivalent
vaccines in a terrible northern hemisphere flu season, and is on track to break even this
year.
The second dose of the chickenpox
vaccine can be given any time,
as long
as it is at least three months after the first dose, but it is typically given when kids are 4 to 6
years old, just before they start kindergarten.
Given questions about how long the
vaccine is effective for, she questioned the efficacy of giving shots to girls
as young
as 11
years old in parts of the world (such
as the U.S.) where women regularly undergo safety Pap screening repeatedly over their lifetimes, saying that the chances of their contracting cervical cancer may be less than the «small» risks associated with the
vaccine.
Although some parents would like to go back to these earlier schedules when kids got fewer
vaccines, it is important to remember another part of history,
as this was also a time when, each
year, people (mainly kids) still got:
maybe Japan also has lower SIDS rates
as a result of changing the age of first vaccination from 2 months to 12 months, SIDS is defined
as sudden unexplained infant death from age 2 months (when first
vaccine usually given) to 1
year
Warning families that pediatricians and pharmaceutical companies are harming children with unneeded drugs and
vaccines, the 63 -
year - old positions himself
as a truth - teller who protects kids by upholding this oath, «Above all, do no harm.»
The Centers for Disease Control and Prevention recommends the influenza
vaccine for everyone over 6 months of age, especially
as kids under 5
years are at highest risk for complications related to the flu.
As a 20
year obgyn RN I do nt know for sure the benefits of taking the IV our sap and no eye gel and hep b
vaccine..
As Reuters and several other news outlets have reported, France's Sanofi Pasteur released a statement that said a 6 -
year analysis of people who received the
vaccine found more severe disease occurred in people who initially were naïve to the virus.
Christie said last
year that parents should have a «measure of choice,»
as «not every
vaccine is created equal and not every disease type is
as great a public health threat
as others.»
«Even when the
vaccine is not a perfect match to the circulating influenza strain,
as is the case this
year, the
vaccine still helps prevent more severe infections if children get sick with the flu,» she says.
The Rice method, known
as pEpitope (pronounced PEE - epih - tope), was invented more than 10
years ago
as a fast, inexpensive way of gauging the effectiveness of proposed flu
vaccine formulations.
The
vaccine is currently voluntary in most U.S. states, and only a smattering of vaccination coverage campaigns exist, such
as those launched by the New York City Department of Health and the Minnesota Department of Health in the past
year.
«The reason researchers change the
vaccine every
year is that they want to specifically match the
vaccine to the particular viruses that are circulating, such
as H1N1.
Danielle Salha says that the ability to publish her
vaccine research was a priority for her when she joined the multinational company Aventis Pasteur
as a postdoc a
year ago.
Dr Derek Gatherer of Lancaster University said: «Every
year we have a round of flu vaccination, where we choose a recent strain of flu
as the
vaccine, hoping that it will protect against next
year's strains.
To date, only six patients (including Menezes) for whom the vaccination strategy failed have survived, the first was 6
year - old Matthew Winkler from Ohio, who was bitten by a rabid bat in 1970 and developed symptoms after receiving a full course of the
vaccine (prior versions of the rabies
vaccine were not
as effective
as current formulations).
Lederman, who says he's «obsessed» with Jenner and has been working on a biography of the scientist for 20
years, is convinced that Jenner's original
vaccine, now named vaccinia, was derived from a virus circulating in horses, not cows,
as folklore has it.
Plague infects a handful of humans and domesticated animals each
year as well, and the team is looking into using the
vaccine in areas where humans spend time, like national parks.
However, the BCG
vaccine was developed 86
years ago, and TB, with increasing drug resistance, now kills more than 1.5 million people each
year, second only to HIV / AIDS
as the world's most deadly infectious disease.
An internationally - recognized scientist with more than 16
years of experience in translational immunoparasitology research and
vaccine development for neglected tropical diseases, Bottazzi's major interest lies in the role of
vaccines as control tools integrated into international public and global health programs and initiatives.
I spent a
year filtering spit and nasal washings, growing influenza in tissue cultures in a minimalist lab, and trying to develop an oral flu
vaccine, all
as part of my Infectious Diseases fellowship thirty
years ago.
One of the hottest trends in immunology — injecting DNA
as a
vaccine — may actually have been invented millions of
years ago.
The
vaccine, which may receive FDA approval
as early
as this month, could potentially save about 2,500 lives a
year in the United States.
After
years of speculation about the promise of cancer
vaccines as a way to use the immune system against tumors, the United States will soon see its first cancer
vaccine hit the market.
Last
year the National Institutes of Health announced plans to put some 180 ex-Coulston chimps currently housed at the Alamogordo Primate Facility back in service, to rejoin the roughly 800 other chimps that serve
as subjects for studies of human diseases, therapies and
vaccines in the U.S., which is the only country apart from Gabon to maintain chimps for this purpose.
Adjuvants, such
as aluminum salts, have been integrated into
vaccines for more than 70
years to augment the body's immune response to pathogens.
After stepping down
as head of the Centers for Disease Control and Prevention (CDC) almost a
year ago, Julie Gerberding has a new gig: She will preside over
vaccine development at the drug giant Merck.
Ding's next goal is to raise $ 5 million so he can spend about five
years studying new
vaccines for human pathogens such
as dengue fever.
Phages would require a less traditional approach to get official approval, such
as the annual process for influenza
vaccines in which manufacturers secure approval of new formulas based on the flu bug that is going around that
year, instead of conducting big clinical trials every time.
The results came
as a surprise to HIV -
vaccine skeptics in the AIDS (acquired immunodeficiency syndrome) research field, whose numbers have increased after
years of failed
vaccine trials.
Flu
vaccine production is always a bit of a gamble, and, unfortunately, the strain the researchers had chosen
as a target wasn't the most virulent one roaming the U.S. that
year.
As Scientific American reported earlier this month, officials from Italy, the U.K., Canada, Norway and Russia met in Rome on February 9, where they announced that their governments would commit the funds for
vaccines against pneumococcus, which causes pneumonia and meningitis that kill up to a million children every
year.
The idea of using messenger RNA molecules
as vaccines has been around for about 30
years, but one of the major obstacles has been finding a safe and effective way to deliver them.
If countries have enough
vaccine, they can reduce disease and death by vaccinating groups at higher risk, such
as pregnant women, those with chronic health conditions, or even all healthy young adults between 15 and 49
years old, the age group that appears most vulnerable.
Plausible vaccination scenarios with a durable
vaccine, the researchers found, are clearly beneficial: such strategies would reduce annual dengue incidence by
as much
as 80 % within five
years, and that annual
vaccine effectiveness approaches 65 % by the end of the 20 -
year forecast period.
Current
vaccines, which require experts to pick the flu strains that they believe are going to circulate in a given
year, are typically 40 to 70 percent effective in the U.S., though in some
years protection is
as low
as 20 percent.
But when a field suffers
as much failure
as the search for an AIDS
vaccine has over the past 30
years, researchers sometimes celebrate glimpses of hope.
In the 30
years since scientists identified HIV
as the cause of AIDS, the virus has proved unbeatable — hiding in the very immune cells that would kill it; reflexively and rapidly mutating; mysteriously persisting in the gut, kidneys, liver, and brain; subverting every
vaccine (the best one so far has given only 30 percent protection); and roaring back to life almost the moment drugs are stopped.
O'Neill's team calls for $ 2 billion over five
years for blue - sky research into antibiotics and other antibacterial measures such
as diagnostics and
vaccines.
Before pertussis
vaccines came into use in the 1930s, the infection killed about 4,000 Americans (mostly infants) a
year — 10 times
as many
as the number of people who died annually from measles and 12 times more than died from smallpox.
So far in tests on mice, plant proteins have worked
as well
as traditional
vaccines, and the U.S. Navy is planning human trials later this
year.
In those days, the Salk polio
vaccine, hailed
as deliverance from the dreaded scourge that crippled and killed thousands of children every
year, ranked
as the hottest thing in medical science.
As Read first argued in a Nature paper 14
years ago, by keeping their hosts alive, such «imperfect» or «leaky»
vaccines could give deadlier pathogens an edge, allowing them to spread when they would normally burn out quickly.
Cholera expert David Sack of Johns Hopkins University in Baltimore, Maryland, doubts that immunity wanes
as quickly
as the data suggest —
vaccine trials indicate it may last several
years.
«Ten
years ago if you chose to delay
vaccines, it wasn't
as big a deal
as it is now, but that is a more dangerous choice now,» Offit says.
In 2012, the UK Department of Health therefore recommended annual vaccination of those aged 2 - 16
years of age with live attenuated influenza
vaccine (LAIV)
as part of the NHS childhood vaccination programme.
He said scientists are still learning how this growth factor controls healing, and ultimate development of the discovery
as a healing agent or
vaccine was still a number of
years away.